ArticleACS pharmacology & translational science2026

Zirconium-89 Labeling and Preliminary Evaluation of Simtuzumab as a Candidate Positron Emission Tomography (PET) Imaging Agent for Human Lysyl Oxidase-like 2 (LOXL2) in the Extracellular Matrix of Solid Tumors.

Graham Ragland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.